Abstract
When guinea pigs are poisoned with lead in the form of commercial white lead administered by mouth in capsules, with a daily dosage of about 300 mg. per kilo of animal, convulsions result on about the fourth day. These convulsions are highly characteristic, being epileptiform in character and exhibiting both clonic and tonic phases. Such animals may die in the first, or in subsequent convulsions, or, if the administration of lead be stopped, they may recover.
If a resting period of sufficient length be allowed after the cessation of convulsions, the survivors will be found to have acquired a partial immunity in respect to the cerebral manifestations of lead poisoning, so that they may be given a larger number of doses of the same size as those first used without producing convulsions. If this process be repeated, the amount of lead which can be administered without producing convulsions may be greatly increased. A limited number of animals thus prepared have reached a point at which four times the usual convulsion-producing dosage has been given without convulsions resulting. During each of the longer periods of administration the usual loss of weight, cachexia and muscular weakness develop, indicating that whatever immunity is produced is against a local action of lead and not against its general toxic effect. There has been noted a marked individual variation in the ability of animals to develop this relative immunity, and in certain instances death has occurred unexpectedly in animals well along in the course of lead administration.
The experimental evidence thus obtained is in accord with the belief of some of the older writers upon lead encephalopathy, that the manifestations of this condition are more apt to be shown by those relatively new to a particular lead hazard than by those who have been long exposed to lead, Clinically, there are found numerous exceptions to this rule, although our experimental results indicate that it is founded upon a scientific basis.
Get full access to this article
View all access options for this article.
